Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India are living with diabetes, while an additional 136 million have prediabetes.
What this means
This story is part of Rail 24's ongoing india coverage. We summarise reporting from News so you can quickly scan what changed and why it matters for travellers, commuters and the wider Indian transport sector, then read the full original article at the source. Rail 24 aggregates trusted india sources and refreshes them continuously so you always see the latest developments in one place.
This india update was reported by News on and curated by Rail 24. For the complete report, visit the original source below.
More India coverage on Rail 24
Rail 24 tracks india's mobility & transport news — railways, metros, airports, highways, evs and policy. Browse the latest India headlines or jump to all news categories.